TRYG Tryg A/S

Reporting of trading in Tryg shares by senior management and their related parties

Reporting of trading in Tryg shares by senior management and their related parties

 CEO Johan Kirstein Brammer has transferred 4,365 Tryg shares at DKK 138.8 for a total amount of DKK 605,862 on 17 April 2024.

                                                          

Attachment



EN
17/04/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tryg A/S

Håkon Astrup
  • Håkon Astrup

Tryg (Buy, TP: DKK185.00) - Building on a solid foundation

We expect focus at the CMD set for 4 December to be on how best to utilise the scale achieved after the RSA transaction. Building on newfound scale in Sweden, together with profitability measures in Norway, we see continued underwriting improvements. In sum, we expect Tryg to update its key financial targets for 2027, with a combined ratio of ≤80% and an insurance service result of DKK8.2bn–8.6bn. We reiterate our BUY and have raised our target price to DKK185 (180), having increased our 2025–20...

ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland

Like clockwork, now time to look to 2027

Q3: Underlying claims in line, 3% UW beat (weather & large losses); Adj. EPS +1% for both 24e (inv.return) and 26e (premiums); Unwarranted P/E discount 24e-25e, BUY into CMD

ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland

Reported UW beat, underlying in line

PTP +3% vs both cons & ABG, driven by 3% better UW; Reported growth inline, '24 guidance repeated ahead of CMD; Stock +0-2% today, cons.est.rev. +0-2%; pos. read to peer GJF

ABGSC Financials Research ... (+4)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland
  • Patrik Brattelius
ABGSC Financials Research ... (+3)
  • ABGSC Financials Research
  • Fredrik Flørnes Støle
  • Jan Erik Gjerland

Continuing on the path towards a CR <80%

Q3: expect continued 30bp improvement, neutral risk/reward. UW -1-2% on lower discounting; '24e adj. EPS +2% (financials). Trading at 5-12% warranted cap. adj. P/E premium to peers: BUY.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch